Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
Elena Daveri, Elisabetta Vergani, Eriomina Shahaj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 13

Showing 13 citing articles:

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 61
Engineered exosomes for studies in tumor immunology
Ahmet Alptekin, Mahrima Parvin, Hasanul Chowdhury, et al.
Immunological Reviews (2022) Vol. 312, Iss. 1, pp. 76-102
Closed Access | Times Cited: 28
LncRNAs has been identified as regulators of Myeloid-derived suppressor cells in lung cancer
Yifan Liu, Yukun Han, Yanhua Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa, Klaudia Klicka, Paweł Włodarski
Cancers (2020) Vol. 12, Iss. 12, pp. 3709-3709
Open Access | Times Cited: 34
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
Linyinxue Dong, Xuechen Tian, Yunqi Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14775-14775
Open Access | Times Cited: 21
The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells
Elham Shokati, Elahe Safari
International Immunopharmacology (2023) Vol. 120, pp. 110267-110267
Closed Access | Times Cited: 11
Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
Izabela Siemińska, Jarosław Baran
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma
Manal S. Fawzy, Afaf T. Ibrahiem, Naglaa A. Bayomy, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1205-1205
Open Access | Times Cited: 11
MicroRNAs/LncRNAs Modulate MDSCs in Tumor Microenvironment
Xiaocui Liu, Shang Zhao, Hongshu Sui, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Lifei Liang, Xiaoqing Xu, Jiawei Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Association of HOTAIR, MIR155HG, TERC, miR-155, -196a2, and -146a Genes Polymorphisms with Papillary Thyroid Cancer Susceptibility and Prognosis
Jelena Karajovic, Božidar Kovačević, Bojana Uzelac, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 485-485
Open Access | Times Cited: 3
Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review
Asghar Arshi, Esmaeil Mahmoudi, Farzaneh Raeisi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
miR-aculous new avenues for cancer immunotherapy
William W. Tang, Kaylyn M. Bauer, Cindy Barba, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Page 1

Scroll to top